Sho Okada

Papers

Total Citations

H-Index

About

Sho Okada is a urologic surgeon and researcher whose work centers on improving surgical outcomes in prostate cancer, particularly through robotic-assisted radical prostatectomy (RARP). His key research areas include preoperative risk stratification, pathological staging, and the refinement of surgical techniques to enhance oncologic control. Okada’s major contribution lies in identifying preoperative predictive factors for seminal vesicle invasion (pT3b), a critical determinant of disease progression and treatment planning. By analyzing clinical and imaging variables, he has developed models that help surgeons anticipate unexpected T-stage upgrades, thereby reducing the risk of incomplete resections and improving patient counseling. His most-cited work, a 2025 study on these predictive factors, has already garnered attention for its practical implications in the operating room. Though early in his career, Okada’s focus on data-driven surgical precision positions him as a rising voice in urologic oncology, with potential to influence guidelines for nerve-sparing and lymph node dissection during RARP. His research bridges the gap between preoperative assessment and intraoperative decision-making, offering tangible benefits for both surgeons and patients navigating prostate cancer treatment.